Midwestern communities like St. Paul contend with high prescription drug prices alongside an 30.1% adult obesity rate and 8.5% adult diabetes rate. Ozempic® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk. Weight Method offers a separate telehealth option: licensed Minnesota providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home shipping to St. Paul.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · St. Paul is already seeing results
GLP-1 weight-loss treatment available to eligible patients in St. Paul, MN. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
For many people in St. Paul, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Semaglutide addresses hormonal drivers involved in body weight regulation. Ozempic® is the FDA-approved Injectable pen Semaglutide product by Novo Nordisk, approved in 2017 for Type 2 diabetes. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The program is priced at $199/month, including the evaluation, the medication, ongoing care, and home delivery to St. Paul.
City life in St. Paul brings convenience in many forms, but it also brings sedentary desk jobs, food delivery temptation, and stress-driven eating patterns that make weight management difficult. Semaglutide therapy works at the biological level — reducing hunger and cravings — so St. Paul residents can make better choices even during their busiest days. Weight Method prescribes compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy, at $199/month through virtual consultations that fit into a lunch break. Compounded Semaglutide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Minnesota and start Ozempic from $199/month.
Get Started NowFree consultation. No commitment.